Empagliflozin and Elderly Patients With HFpEF Empagliflozin and Elderly Patients With HFpEF

Do elderly patients with HFpEF benefit as much as younger patients from treatment with an SGLT2 inhibitor? A new study demonstrates its efficacy across all age groups.Journal of the American College of Cardiology

Source: Medscape Today Headlines - October 17, 2022 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news